X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

CELUW

Closed

Celularity Inc

0.0476
+0.0033 (+7.45%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 0.0443
Day's Range: 0.0476 - 0.0476
Send
When Written:
 
0.06
Celularity Inc is a biotechnology company that focuses on developing and commercializing innovative cellular therapies for cancer and other diseases. The company was founded in 2017 by Dr. Robert Hariri, a pioneer in the field of regenerative medicine.

Celularity's proprietary technology platform uses placental cells to create a range of cellular therapies, including CAR-T cells, NK cells, and mesenchymal stem cells. These therapies have shown promising results in preclinical and clinical studies for the treatment of cancer, autoimmune diseases, and degenerative disorders.

The company has partnerships with several leading pharmaceutical companies, including United Therapeutics, Sorrento Therapeutics, and Humanigen. In 2020, Celularity announced a merger with GX Acquisition Corp, a special purpose acquisition company (SPAC), to become a publicly traded company on the Nasdaq.

Celularity's mission is to improve patient outcomes by developing innovative cellular therapies that harness the power of the immune system to fight disease.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X